Target intelligence / Profile preview

Modulation of gut microbiota composition

Molecular classification
Other
01

Overview

Modulation of gut microbiota composition refers to the intentional alteration—through dietary interventions, probiotics/prebiotics/synbiotics/postbiotics administration, fecal transplants, or other means—of the complex community structure and function within the human gastrointestinal tract. The gut microbiota is not a single molecule or receptor but rather a diverse ecosystem comprising bacteria, fungi, archaea, viruses and their collective genes. This ecosystem plays essential roles in digestion/metabolism; maintenance of mucosal barrier integrity; development/regulation of immunity; production/modification/absorption/excretion/metabolism-of-nutrients-and-drugs; synthesis-of-neuroactive-compounds-affecting-the-gut-brain-axis; modulation-of-inflammation-and-host-defense-mechanisms. Dysbiosis—a disruption in this balance—is implicated in numerous diseases including neurodegenerative disorders like Parkinson’s disease and Alzheimer’s disease, cardiovascular conditions, metabolic syndrome, gastrointestinal disorders such as colitis/inflammatory bowel diseases, among others. While “modulation” itself is not a molecular target but rather an approach/strategy/intervention area aimed at restoring healthy homeostasis by shifting microbial populations/functions toward beneficial profiles—it is increasingly recognized as both a diagnostic marker set (“microbial signatures”) and therapeutic avenue. Note on correctness: “Modulation of gut microbiota composition” does not refer to a specific molecule/receptor/protein/enzyme/transporter/etc.; it describes an intervention strategy targeting an entire ecological system. Therefore it should not be classified as a canonical drug target per se. If you need information about specific molecular targets involved in modulating the gut microbiome (such as receptors mediating microbe-host interactions), please specify further.

Other names
Gut microbiota modulationAlteration of gut microbiomeMicrobiota-targeted interventionRegulation of intestinal flora
02

Mechanism of action

Restoration or alteration of microbial community structure to a healthy state by increasing beneficial bacteria and/or reducing pathogenic species. Modulation of microbial metabolites such as short-chain fatty acids and bile acids that influence host physiology and immune responses. Reduction in inflammation via changes in microbial-derived molecules or immune signaling pathways (e.g., suppression of oxidative stress).

03

Biological functions

Maintenance of host intestinal homeostasisEnergy absorptionImmune regulationMetabolism of nutrients and drugsModulation of inflammationGut-brain axis signaling
04

Disease associations

Neurodegenerative disease (e.g., Parkinson’s disease, Alzheimer’s disease)Cardiovascular diseaseMetabolic diseases (e.g., obesity, diabetes)Gastrointestinal diseases (e.g., inflammatory bowel disease)Infection
05

Safety considerations

Risk of infection with fecal microbiota transplantation in immunocompromised patients or those with underlying conditionsUnpredictable effects due to inter-individual variability in baseline microbiome compositionPotential for adverse metabolic or immune reactions depending on the intervention used
06

Interacting drugs

Probiotics (e.g., Lactobacillus salivarius AP‑32, Lactobacillus plantarum DP189)

5 more in the full profile.

07

Biomarkers

Firmicutes/Bacteroidetes ratio as an indicator for dysbiosis or health statusAbundance/diversity/evenness indices for overall gut flora composition

Beyond the preview

Go deeper on Modulation of gut microbiota composition.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modulation of gut microbiota composition.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call